Officiële publicaties Lonza Group AG

Aandelen

Vertraagde tijd Swiss Exchange Andere beurzen 17:31:59 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
510,4 ^CHF	-2,30%		+0,71%	+44,30%

09/04	NeuroSense Therapeutics Ltd. werkt samen met Lonza om Exosome-gebaseerde Biomarkers te identificeren, om de behandeling en diagnostiek van neurodegeneratieve ziekten te bevorderen	CI
04/04	Lonza sluit productieovereenkomst voor Acumen's kandidaat-geneesmiddel voor de ziekte van Alzheimer	MT

Mixed general shareholder meeting	03/04	CO
Mixed general shareholder meeting	03/04	CO
Remuneration Report	03/04	CO
Annual ESG Report	03/04	CO
Annual Report	03/04	CO
Changes in management and corporate officers	02/04	CO
Business information	20/03	CO
Slide show results	26/01	CO
Annual results	26/01	CO
Annual results	26/01	CO
Changes in management and corporate officers	26/01	CO
Financial report	26/01	CO
Slide show half-year results	21-07-23	CO
Half-year report	21-07-23	CO
1st-half-year results	21-07-23	CO
Minutes of the general assembly	05-05-23	CO
Minutes of the general assembly	05-05-23	CO
Remuneration Report	27-03-23	CO
Annual ESG Report	27-03-23	CO
Financial report	27-03-23	CO
Annual Report	27-03-23	CO
Slide show results	25-01-23	CO
Annual results	25-01-23	CO
Changes in management and corporate officers	12-09-22	CO
Slide show half-year results	22-07-22	CO